Page 8 - Nasdaq Atra News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The small-cap Russell 2000 gained over 10% in July, compared to a jump of 9.1% for the S&P 500. It is the biggest percentage-point outperformance

Atara Biotherapeutics (NASDAQ:ATRA – Get Rating) was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating in a note issued to investors on Wednesday, MarketBeat.com reports. They currently have a $10.00 target price on the biotechnology company’s stock. JPMorgan Chase & Co.‘s target price suggests a potential upside […]

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating)’s stock price was up 10.4% during mid-day trading on Tuesday . The stock traded as high as $6.49 and last traded at $6.48. Approximately 34,361 shares traded hands during trading, a decline of 97% from the average daily volume of 1,117,919 shares. The stock had previously closed at […]

Equities research analysts forecast that Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) will post earnings per share (EPS) of ($0.91) for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for Atara Biotherapeutics’ earnings, with estimates ranging from ($0.97) to ($0.79). Atara Biotherapeutics also posted earnings per share of ($0.91) in the […]

Equities analysts expect that Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) will post sales of $8.84 million for the current fiscal quarter, according to Zacks. Three analysts have made estimates for Atara Biotherapeutics’ earnings. The lowest sales estimate is $5.80 million and the highest is $14.73 million. Atara Biotherapeutics reported sales of $3.87 million in […]